ArticleRadiology case reports2025
False positive PET scan of hereditary leiomyomatosis and renal cell cancer: A case report.
Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an inherited condition, predisposing patients to develop cutaneous or uterine leiomyomas along with aggressive type 2 papillary renal cell carcinoma (RCC). Patients are routinely monitored for cancer and metastases. A 62-year-old man with HLRCC presented to the dermatology clinic, referred by oncology because he potentially had metastatic (RCC) based on a recent PET scan. The patient's medical history revealed stage 1 papillary RCC of the right kidney and mid-left kidney (both surgically removed) and multiple cutaneous leiomyomas. Physical exam revealed multiple nodules on the abdomen, lower extremities, and left shoulder. PET scan showed a hypermetabolic cutaneous lesion in the superior aspect of the left shoulder, concerning for metastatic disease. A punch biopsy of the 9 mm left shoulder nodule was performed. Microscopic evaluation showed proliferation of spindled cells arranged in intersecting fascicles within the dermis. The spindle cells had cigar-shaped nuclei with abundant eosinophilic cytoplasm. There was no cytologic atypia or increased mitotic activity. The cells were positive for desmin immunostain. The patient was offered an excision or biopsy of the benign leiomyoma, and he requested a biopsy. He was advised to seek further treatment if the lesions became symptomatic. Patients with HLRCC may have benign cutaneous leiomyomas that are suspected of being metastatic disease, with false positive PET scans. Care should be taken to counsel patients on the potential for false-positive PET scans in this condition, and screening should be conducted in the case of multiple cutaneous or uterine leiomyomas.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.